Showing 2661-2670 of 4067 results for "".
- Dermal Repair Complex Wins 2025 Nourish Award for Beauty and Collagen Supplementhttps://reachmd.com/news/dermal-repair-complex-wins-2025-nourish-award-for-beauty-and-collagen-supplement/2484256/Beverly Hills MD Dermal Repair Complex has received the 2025 Nourish Award in the Beauty and Collagen category, according to a company announcement. The supplement, developed by cosmetic surgeons John Layke, DO, and Payman Danielpour, MD, is marketed as a skin-focused nutritional product formulat
- Targeting Regulated Cell-Death Pathways in Severe Cutaneous Adverse Reactionshttps://reachmd.com/news/targeting-regulated-cell-death-pathways-in-severe-cutaneous-adverse-reactions/2484242/Investigators have linked formyl peptide receptor 1 (FPR1)–dependent necroptosis to epidermal cell death in SJS/TEN–type reactions and described an FPR1-targeted inhibitor that reduced
- Breakthrough in Vision Restoration: BCI Retinal Implant Offers New Hope for AMD Patientshttps://reachmd.com/news/breakthrough-in-vision-restoration-bci-retinal-implant-offers-new-hope-for-amd-patients/2484218/A wireless BCI retinal implant restored form central vision in patients with geographic atrophy in a peer-reviewed New England Journal of Medicine trial
- FDA Approval of Cemiplimab: A New Era for High-Risk CSCC Treatmenthttps://reachmd.com/news/fda-approval-of-cemiplimab-a-new-era-for-high-risk-cscc-treatment/2484102/In a significant step forward for skin cancer management, the U.S. Fo
- Examining Nerandomilast Efficacy in Idiopathic Pulmonary Fibrosis: Insights from CHEST 2025https://reachmd.com/news/examining-nerandomilast-efficacy-in-idiopathic-pulmonary-fibrosis-insights-from-chest-2025/2484078/Nerandomilast (Jascayd) slowed forced vital capacity (FVC) decline over 52 weeks in the FIBRONEER‑IPF Phase 3 trial
- Emerging Treatments for CLE Highlighted at Fall Clinicalhttps://reachmd.com/news/emerging-treatments-for-cle-highlighted-at-fall-clinical/2484091/Cutaneous lupus erythematosus (CLE) patients often face long treatment timelines, drug toxicity, and misdiagnoses, but recent advances in mechanism-based agents mark a significant step forward, Lauren Graham, MD, PhD, and Alisa Femia, MD, said during a presentation at the 2025 Fall Clinical Derma
- Marini SkinSolutions Launches Topical Serum to Complement Neuromodulator Injectionshttps://reachmd.com/news/marini-skinsolutions-launches-topical-serum-to-complement-neuromodulator-injections/2483956/Marini SkinSolutions™ has introduced NeuroSmooth™, a topical peptide-based serum formulated to support and enhance outcomes associated with neuromodulator injections. The serum contains neuromodulating peptides, collagen stimulators, and ingredients aimed at improvi
- Aerosol Sampling Detects TB DNA in Primary Care Patientshttps://reachmd.com/news/aerosol-sampling-detects-tb-dna-in-primary-care-patients/2483913/A recent study published in Open Forum Infectious Diseases investigates a novel, non‑sputum approach to tuberculosis (T
- Portable Air Sampler Detects Airborne TB DNA in South African Clinicshttps://reachmd.com/news/portable-air-sampler-detects-airborne-tb-dna-in-south-african-clinics/2483908/A study published in Open Forum Infectious Diseases reports that a small, electrostatic air-sampling device can detect aerosolized
- Topical Cream Shows Promise in Preventing Chemotherapy-Induced Hand Neuropathyhttps://reachmd.com/news/topical-cream-shows-promise-in-preventing-chemotherapy-induced-hand-neuropathy/2483854/Researchers in Spain and Belgium have reported that a specially formulated topical cream can significantly reduce the incidence and severity of chemotherapy‑induced neuropathy in the hands. The international, randomized clinical trial, described in